Health Catalyst, Inc. — Director's Dealing 2021

Jun 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-06-03

Reporting Person: Llewelyn Linda (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-03	Common Stock	M	1100.00	$10.80	Acquired	41457.00	Direct
2021-06-03	Common Stock	M	1100.00	$11.78	Acquired	42557.00	Direct
2021-06-03	Common Stock	S	3186.00	$52.7748	Disposed	39371.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-03	Stock Option (Right to Buy)	$11.78	M	1100.00	Disposed	2028-01-24	Common Stock (1100.00)	Direct
2021-06-03	Stock Option (Right to Buy)	$10.80	M	1100.00	Disposed	2028-09-27	Common Stock (1100.00)	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.

F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.16 to $53.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

F3: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.

F4: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.